Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$217,832,734
+$31,261,311 QoQ
Shares Held
6,160,428
-7.6% QoQ
Ownership
3.70%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,198,269,231 across 49 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,787,019 | $1,059,666,526 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,418,897 | $318,665,490 | |
| 3 | ALKS |
Alkermes plc.
This page
|
6,160,428 | $217,832,734 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,859,728 | $108,857,232 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,705,222 | $88,142,925 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,989,100 | $55,358,132 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,469,449 | $48,594,678 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,118,080 | $43,971,340 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,832,734 | 6,160,428 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $186,571,423 | 6,668,028 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $188,775,840 | 6,292,528 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $166,228,677 | 5,810,160 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $189,496,100 | 5,738,828 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $157,568,217 | 5,478,728 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $151,734,657 | 5,421,031 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $132,160,327 | 5,483,831 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $159,365,177 | 5,887,151 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $167,808,053 | 6,049,317 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $171,309,524 | 6,116,013 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $161,708,726 | 5,166,413 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $139,227,957 | 4,938,913 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $147,491,124 | 5,644,513 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $124,068,003 | 5,556,113 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $158,560,641 | 5,322,613 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $128,077,422 | 4,868,013 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $111,902,580 | 4,810,945 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $146,319,824 | 4,744,482 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $129,431,590 | 5,278,613 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $113,303,782 | 6,065,513 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $138,760,489 | 6,955,413 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $138,490,602 | 7,135,013 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $103,551,649 | 7,181,113 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||